News, Scientific publications and Events

Uro-gynecology News UTIPRO® PLUS / UTIPRO® PLUS AF

UTIPRO PLUS® launched in Finland

We are pleased to announce the launch of UTIPRO® PLUS, our product for uncomplicated UTIs, in Finland. The product is commercialized over the Finnish territory under the umbrella brand UrinCUR / Utipro plus and it is distributed by RFSU, our partner for the product on the Swedish and Norwegian territory as well.

Uro-gynecology Scientific Publication UTIPRO® PLUS / UTIPRO® PLUS AF UTIPRO® PLUS

Uncomplicated Urinary Tract Infection in Adults - Noventure new Publication

We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs The trial "Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults" has been published on Urologia Internationalis. https://www.ncbi.nlm.nih.gov/pubmed/30889607 In the study, safety and efficacy of a Xyloglucan based medical device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated UTIs in adults.

Uro-gynecology News UTIPRO® PLUS / UTIPRO® PLUS AF UTIPRO® PLUS

News on NOVENTURE participation at EAU 2019 in BARCELONA

For the fourth consecutive year, Noventure was present at the annual congress of the EAU - European Association of Urology- that took place in Barcelona 15th – 19th March 2019. Noventure participation to EAU is to confirm its presence in the urology field with its medical device for oral use UTIPRO PLUS intended to control and prevent uncomplicated UTIs.